Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
195.32
-8.89 (-4.35%)
At close: May 13, 2026, 4:00 PM EDT
196.13
+0.81 (0.41%)
After-hours: May 13, 2026, 7:36 PM EDT
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
Insurance Carriers Revenue | 2.36B | 2.17B | 1.57B | | | | | | | | | | | |
Insurance Carriers Revenue Growth | 8.54% | 38.13% | 64.73% | | | | | | | | | | | |
Laboratory Partners Revenue | 111.10M | 103.11M | 97.21M | | | | | | | | | | | |
Laboratory Partners Revenue Growth | 7.74% | 6.07% | -1.70% | | | | | | | | | | | |
| 33.20M | 31.82M | 27.88M | | | | | | | | | | | |
| 4.36% | 14.10% | -5.56% | | | | | | | | | | | |
| 1,000.00 | -7.00K | -4.00K | | | | | | | | | | | |
| 2.50B | 2.31B | 1.70B | | | | | | | | | | | |
| 8.45% | 35.90% | 56.75% | | | | | | | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
| 2.46B | 2.26B | 1.66B | | | | | | | | | | | |
United States Revenue Growth | 8.54% | 36.59% | 58.24% | | | | | | | | | | | |
Americas, excluding US Revenue | 10.06M | 9.35M | 6.62M | | | | | | | | | | | |
Americas, excluding US Revenue Growth | 7.59% | 41.30% | 34.88% | | | | | | | | | | | |
Europe, Middle East, India, Africa Revenue | 24.86M | 24.48M | 23.88M | | | | | | | | | | | |
Europe, Middle East, India, Africa Revenue Growth | 1.54% | 2.50% | 4.70% | | | | | | | | | | | |
Asia Pacific and Other Revenue | 8.45M | 8.01M | 8.66M | | | | | | | | | | | |
Asia Pacific and Other Revenue Growth | 5.43% | -7.48% | 20.04% | | | | | | | | | | | |
| 1,000.00 | -8.00K | -6.00K | | | | | | | | | | | |
| 2.50B | 2.31B | 1.70B | | | | | | | | | | | |
| 8.45% | 35.90% | 56.75% | | | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
|---|
| 3.68M | 3.53M | 3.06M | | | | | | | | | | | |
| 4.49% | 15.04% | 22.78% | | | | | | | | | | | |
| 3.63M | 3.47M | 3.00M | | | | | | | | | | | |
| 4.57% | 15.55% | 23.71% | | | | | | | | | | | |
| 3.47M | 3.34M | 2.93M | | | | | | | | | | | |
| 3.81% | 14.22% | 22.54% | | | | | | | | | | | |
Tests Reported in Laboratory | 3.42M | 3.29M | 2.87M | | | | | | | | | | | |
Tests Reported in Laboratory Growth | 3.87% | 14.69% | 23.41% | | | | | | | | | | | |
Updated May 7, 2026. Data Source:
Fiscal.ai.